Jiang Xiaomeng's Experience in Participating in Zheshang University Talks
Release time:
2020-07-22
Jiang Xiaomeng's Experience in Participating in Zhejiang Business Conference
News 11# July 13 , the 5th World Zhejiang Business Conference with the theme of "Gathering High Quality and Building a Chinese Dream Together" was held in Hangzhou International Expo Center. Jiang Xiaomeng, Secretary of the Party Committee and Chairman of Zhejiang Jianfeng Group, attended the conference, represented Jinhua entrepreneurs to participate in the development promotion ceremony of integrating into the Yangtze River Delta, and was interviewed by the media to talk about his experience.
is the largest, highest specification and most influential Zhejiang business event in Zhejiang Province sponsored by Zhejiang Provincial Party Committee and Provincial Government. The World Zhejiang Business Conference invited more than 2700 Zhejiang business representatives and friendly business leaders from 67 countries and regions in the world and 31 provinces and cities in the country, including representatives of the world's 500 top enterprises, representatives of well-known Chinese businessmen and foreign businessmen, representatives of foreign consulate officials, representatives of economic and trade institutions and important chambers of commerce of countries along the "Belt and Road Initiative" route, and famous experts and scholars attended the meeting. The conference announced the opening of the Zhejiang Global Service Platform for Overseas Chinese, the Zhejiang Financial Comprehensive Service Platform, and the Zhejiang Enterprise Service Comprehensive Platform, and the signing ceremony of the "Four Major Construction" major projects was held on the spot. Eleven prefectural and municipal Zhejiang businessmen Representatives came to the stage one by one to light up the urban area where they are located on the map of Zhejiang Province displayed on the large screen. Jiang Xiaomeng, as a representative of Wu businessmen in Jinhua City, lit up the Jinhua Block on behalf of the entrepreneurs in our city at the helping ceremony, enabling Jinhua, an advanced manufacturing base in the golden south wing of the Yangtze River Delta, to integrate into the integrated development of the Yangtze River Delta. After the
meeting, Jiang Xiaomeng was interviewed by the news broadcast program of Jinhua TV station. Jiang Xiaomeng said that he had a deep feeling at the Zhejiang business conference. Che Jun, secretary of the Zhejiang provincial party Committee, said at the conference that "Zhejiang is good, Zhejiang is good, Zhejiang is good, Zhejiang is better". The same is true in Jinhua, "Jinhua is good, Wu is good, Jinhua is better". Zheshang is a very strong and positive group. At the same time, the government is also sincerely promoting the development of enterprises. As a private enterprise, it must actively integrate into the integrated development of the Yangtze River Delta. As a Jinhua enterprise, it is also a part of the development of the Yangtze River Delta. The key is how to use one's own knowledge, skills, accumulation, and opportunities to make the most perfect combination to develop oneself. Only the organic combination of all elements can make Jinhua private enterprises better integrate into the tide of development and obtain real development space. (Fonse)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31